← Leaderboards
Deborah Davis Ascheim
Emory University
$3,521,553
Attributed
$7,376,440
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–14$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,376,440 · 2
By mechanism
P50$6,376,440 · 1
RC1$1,000,000 · 1
Top collaborators
- Roger J. Hajjar3 shared
- Joseph John Derose2 shared
- John Daniel Puskas2 shared
Most similar at Emory University
Same institution · by research overlap
- T. Richard Nichols$6,891,929
- Stephen M Laconte$8,688,903
- Leslie S Kean$43,609,566
- Muxiang Zhou$8,074,026
- Wolfram Siede$1,853,450
Others in their field
Top investigators on “Manuals”
- Jeffrey P Krischer · University Of South Florida$584,908,280
- George R Seage · Abt Associates, Inc.$174,003,449
- Elizabeth A Thom · George Washington University$162,412,272
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$150,649,219
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Christopher McKay · Battelle Memorial Institute$134,148,552
Research focus
ManualsGrantElementsInnovationHeartProtocols DocumentationCoronaryElectronic DataEventInformed ConsentResearch InfrastructureCardiacSafetySiteAdjudicationCase Report FormCoronary ArteryDesignClinical ResearchEnrollmentOperationCardiopulmonaryCardiomyopathiesArea
Grant awards (5)
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure$2,082,299
P50 · FY2014 · HL
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure$2,125,769
P50 · FY2013 · HL
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure$2,168,372
P50 · FY2012 · HL
Hybrid revascularization vs percutaneous coronary intervention: A Planning Grant$500,000
RC1 · FY2010 · HL
Hybrid revascularization vs percutaneous coronary intervention: A Planning Grant$500,000
RC1 · FY2009 · HL